Stryker's Stryker Sales unit secured a $100 million contract modification from the US Defense Logistics Agency, a development that coincided with a 2.7% share price move. The contract news pushed Stryker higher, with the stock last closing at $327.70. The most followed narrative on Stryker currently points to a fair value of $386.80 per share, suggesting the stock is 15.3% undervalued. That valuation rests on a detailed view of procedure demand, margins, and how the business responds to hospital digitization over time. However, the narrative still relies on smooth regulatory approvals and stable procedure volumes, and setbacks in either could quickly challenge today's pricing optimism.
Stryker CorporationWins $100 million contract from US Defense Logistics Agency, boosting demand for its products.
